Table 2B Cross-tables of expression of HER1/ERBB1 and HER2/ERBB2

From: Uncoupling of EGFR–RAS signaling and nuclear localization of YBX1 in colorectal cancer

Parameter

HER1 positive (%)

HER1 negative (%)

P-value

HER2 positive (%)

HER2 negative (%)

P-value

All cases

306 (72)

107 (25)

 

336 (79)

87 (21)

 

Age

 >72

175 (74)

63 (26)

0.528

184 (77)

54 (23)

0.221

 <72

141 (76)

44 (24)

 

152 (82)

33 (18)

 

Gender

 Male

182 (77)

53 (23)

0.147

191 (81)

44 (19)

0.294

 Female

134 (71)

54 (29)

 

145 (77)

43 (23)

 

pT status

 pT1/pT2

72 (73)

26 (27)

0.7

75 (77)

23 (23)

0.394

 pT3/pT4

236 (75)

77 (25)

 

252 (81)

61 (19)

 

Nodal status

 N0

164 (77)

50 (23)

0.355

170 (79)

44 (21)

0.997

 N1

152 (73)

57 (27)

 

166 (79)

43 (21)

 

Metastasis

 M0

278 (75)

91 (25)

0.433

294 (80)

75 (20)

0.747

 M1

38 (70)

16 (30)

 

42 (78)

12 (22)

 

Grade

 G1

3 (75)

1 (25)

0.974

4 (100)

0 (0)

0.305

 G2/G3

306 (74)

106 (26)

 

326 (79)

86 (21)

 

R status

 R0

280 (74)

97 (26)

0.429

301 (80)

76 (20)

0.771

 R1

18 (82)

4 (18)

 

17 (77)

5 (23)

 

Localization

 Right colon

126 (72)

49 (28)

0.123

127 (73)

48 (27)

0.005

 Left colon

177 (79)

48 (21)

 

189 (84)

36 (16)

 

KRAS status

 WT

241 (74)

86 (26)

0.079

261 (80)

66 (20)

0.924

 MUT

45 (85)

6 (15)

 

42 (79)

11 (21)